Viking Gross Profit from 2010 to 2024

VKTX Stock  USD 51.99  0.60  1.14%   
Viking Therapeutics Gross Profit yearly trend continues to be fairly stable with very little volatility. Gross Profit is likely to outpace its year average in 2024. Gross Profit is the profit Viking Therapeutics makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services. View All Fundamentals
 
Gross Profit  
First Reported
2013-12-31
Previous Quarter
-75 K
Current Value
-87 K
Quarterly Volatility
75.5 K
 
Yuan Drop
 
Covid
Check Viking Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Viking Therapeutics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 277.4 K, Interest Expense of 83.6 K or Selling General Administrative of 38.9 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 5.29. Viking financial statements analysis is a perfect complement when working with Viking Therapeutics Valuation or Volatility modules.
  
Check out the analysis of Viking Therapeutics Correlation against competitors.
For more information on how to buy Viking Stock please use our How to Invest in Viking Therapeutics guide.

Latest Viking Therapeutics' Gross Profit Growth Pattern

Below is the plot of the Gross Profit of Viking Therapeutics over the last few years. Gross profit is a required income statement account that reflects total revenue of Viking Therapeutics minus its cost of goods sold. It is profit before Viking Therapeutics operating expenses, interest payments and taxes. Gross profit is also known as gross margin. It is the profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services. Viking Therapeutics' Gross Profit historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Viking Therapeutics' overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported 010 Years Trend
Slightly volatile
   Gross Profit   
       Timeline  

Viking Gross Profit Regression Statistics

Arithmetic Mean(93,711)
Geometric Mean0.00
Coefficient Of Variation(148.33)
Mean Deviation126,379
Median0.00
Standard Deviation139,002
Sample Variance19.3B
Range306.7K
R-Value(0.78)
Mean Square Error8B
R-Squared0.61
Significance0.0005
Slope(24,359)
Total Sum of Squares270.5B

Viking Gross Profit History

2024-277.4 K
2023-292 K
2022-291 K
2021-296 K
202010.7 K
2019-260 K

Other Fundumenentals of Viking Therapeutics

Viking Therapeutics Gross Profit component correlations

-0.87-0.820.670.310.881.01.0-0.230.88-0.83-0.660.680.95-0.610.9-0.110.980.98-0.61
-0.870.96-0.87-0.51-0.79-0.89-0.880.15-0.650.740.59-0.62-0.760.71-0.840.1-0.82-0.820.71
-0.820.96-0.92-0.59-0.78-0.84-0.840.03-0.610.780.67-0.69-0.70.7-0.830.0-0.77-0.770.7
0.67-0.87-0.920.720.640.70.7-0.010.45-0.63-0.530.540.54-0.660.69-0.030.60.61-0.66
0.31-0.51-0.590.720.440.360.350.050.25-0.4-0.340.390.31-0.240.460.020.340.34-0.24
0.88-0.79-0.780.640.440.880.88-0.160.93-0.91-0.740.830.93-0.240.990.070.920.93-0.24
1.0-0.89-0.840.70.360.881.0-0.220.88-0.84-0.660.690.94-0.620.9-0.110.970.97-0.62
1.0-0.88-0.840.70.350.881.0-0.220.88-0.84-0.660.690.94-0.620.9-0.110.970.97-0.62
-0.230.150.03-0.010.05-0.16-0.22-0.22-0.22-0.16-0.460.4-0.290.01-0.260.83-0.28-0.280.01
0.88-0.65-0.610.450.250.930.880.88-0.22-0.88-0.70.750.94-0.180.910.00.920.93-0.18
-0.830.740.78-0.63-0.4-0.91-0.84-0.84-0.16-0.880.94-0.94-0.810.32-0.88-0.25-0.82-0.830.32
-0.660.590.67-0.53-0.34-0.74-0.66-0.66-0.46-0.70.94-0.95-0.620.27-0.68-0.45-0.64-0.640.27
0.68-0.62-0.690.540.390.830.690.690.40.75-0.94-0.950.7-0.190.770.520.70.7-0.19
0.95-0.76-0.70.540.310.930.940.94-0.290.94-0.81-0.620.7-0.350.93-0.110.990.99-0.35
-0.610.710.7-0.66-0.24-0.24-0.62-0.620.01-0.180.320.27-0.19-0.35-0.320.17-0.45-0.451.0
0.9-0.84-0.830.690.460.990.90.9-0.260.91-0.88-0.680.770.93-0.32-0.050.940.94-0.32
-0.110.10.0-0.030.020.07-0.11-0.110.830.0-0.25-0.450.52-0.110.17-0.05-0.12-0.120.17
0.98-0.82-0.770.60.340.920.970.97-0.280.92-0.82-0.640.70.99-0.450.94-0.121.0-0.45
0.98-0.82-0.770.610.340.930.970.97-0.280.93-0.83-0.640.70.99-0.450.94-0.121.0-0.45
-0.610.710.7-0.66-0.24-0.24-0.62-0.620.01-0.180.320.27-0.19-0.351.0-0.320.17-0.45-0.45
Click cells to compare fundamentals

About Viking Therapeutics Financial Statements

Viking Therapeutics investors use historical fundamental indicators, such as Viking Therapeutics' Gross Profit, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Viking Therapeutics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Gross Profit-292 K-277.4 K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Viking Stock Analysis

When running Viking Therapeutics' price analysis, check to measure Viking Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Viking Therapeutics is operating at the current time. Most of Viking Therapeutics' value examination focuses on studying past and present price action to predict the probability of Viking Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Viking Therapeutics' price. Additionally, you may evaluate how the addition of Viking Therapeutics to your portfolios can decrease your overall portfolio volatility.